VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10043769 | HBV | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS30006097 | HIV | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS30032266 | HIV | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS20032482 | HPV | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS20037421 | HPV | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS44031219 | HTLV-1 | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
TVIS44017474 | HTLV-1 | ENSG00000111716.14 | protein_coding | LDHB | No | No | 3945 | P07195 Q5U077 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | LDHB |
---|---|
DrugBank ID | DB00157 |
Drug Name | NADH |
Target ID | BE0000068 |
UniProt ID | P07195 |
Regulation Type | |
PubMed IDs | 17139284; 17016423; 12054772; 16198644; 4303363 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Razeto A, Kochhar S, Hottinger H, Dauter M, Wilson KS, Lamzin VS: Domain closure, substrate specificity and catalysis of D-lactate dehydrogenase from Lactobacillus bulgaricus. J Mol Biol. 2002 Apr 19;318(1):109-19.@@Mdluli K, Booth MP, Brady RL, Rumsby G: A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism. Biochim Biophys Acta. 2005 Dec 1;1753(2):209-16. Epub 2005 Aug 22.@@Clausen J: Lactate dehydrogenase isoenzymes of sperm cells and tests. Biochem J. 1969 Jan;111(2):207-18. |
Groups | Approved; Nutraceutical |
Direct Classification | (5'->5')-dinucleotides |
SMILES | NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
Pathways | Ethylmalonic Encephalopathy; 3-Methylglutaconic Aciduria Type III; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Caffeine Metabolism; Fructose and Mannose Degradation; Isovaleric Aciduria; Lysine Degradation; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Glycerol Phosphate Shuttle; Zellweger Syndrome; Propionic Acidemia; Glycolysis; Xanthine Dehydrogenase Deficiency (Xanthinuria); S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Tryptophan Metabolism; Glutaric Aciduria Type I; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Glycine N-Methyltransferase Deficiency; Dimethylglycine Dehydrogenase Deficiency; Androgen and Estrogen Metabolism; Nucleotide Sugars Metabolism; 3-Methylglutaconic Aciduria Type IV; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Malate-Aspartate Shuttle; Folate Metabolism; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease; Glycerol Kinase Deficiency; Adenylosuccinate Lyase Deficiency; Cysteine Metabolism |
PharmGKB | PA164755085 |
ChEMBL | CHEMBL1234616 |